Aruxil 30 mg+10 mg is a Product of the Generic Almitrine Bismesylate + Raubasine

Aruxil 30 mg+10 mg belongs to the generic category of Almitrine Bismesylate + Raubasine. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Aruxil 30 mg+10 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Almitrine Bismesylate + Raubasine and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Aruxil 30 mg+10 mg

Aruxil 30 mg+10 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Aruxil 30 mg+10 mg is provided below to help users gain a clear understanding of this medicine.

What Is Aruxil 30 mg+10 mg Indications and Uses?

This tablet is indicated for-

Reduction of neurological damage & accelerates recovery after cerebral stroke
Minor age-related neurological disorders
Some visual disorders related to the circulation
Some disorders of the inner ear related to circulation (hearing loss, dizziness, buzzing sounds in the ear).

Pharmacology (Source, Chemical and Physical Composition) Of Aruxil 30 mg+10 mg

Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.

Dosage And Administration of Aruxil 30 mg+10 mg

1 tablet once or twice daily (taken separately, several hours apart), without exceeding 2 tablets per day. Or, as directed by the registered physicians.

Drug Interactions of Aruxil 30 mg+10 mg

Do not associate with MAO-l (monoamine oxidase inhibitor), Not to be used concurrently with other almitrine-containing preparations.

Side Effects of Aruxil 30 mg+10 mg

Weight loss, nausea, sensations of heaviness or burning in the stomach, gastrointestinal disorders, diarrhoea or constipation, insomnia, drowsiness, agitation, anxiety, dizziness, palpitations.

Use During Pregnancy and Lactation

It is not recommended in pregnancy. It should be used with caution only when the expected benefit to the mother is greater than the possible risk to the fetus.

Precautions And Warnings for Aruxil 30 mg+10 mg

Due to the presence of lactose, this drug should not be used in the case of galactosemia, of glucose and galactose malabsorption syndrome or of lactose deficiency (rare metabolic diseases). Do not exceed the recommended dose.

Therapeutic Class

Cerebral vasodilator & Neurosensory oxygenator drugs

Storage Conditions of It

Store at a cool and dry place, protected from light and moisture. Keep out of reach of children.

Aruxil 30 mg+10 mg is a Product of the Generic Almitrine Bismesylate + Raubasine

Aruxil 30 mg+10 mg

Opsonin Pharma Ltd. · Tablet

Almitrine Bismesylate + Raubasine